Get started
Elite Pharmaceuticals, Inc.Elite Pharmaceuticals, Inc.Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc.

No trades
No trades
OverviewFinancialsFilingsNewsCommunityTechnicalsSeasonals
Full chart
Full chart

Peers for comparison



Key stats


Market capitalization
‪256.04 M‬ USDMicro cap
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
9.0038
Basic EPS (TTM)
0.0528 USD
Net income (FY)
‪44.87 M‬ USD
Revenue (FY)
‪148.87 M‬ USD
Shares float
‪835.96 M‬
Beta (1Y)
−0.07

Employees


Employees (FY)
65
Change (1Y)
−3−4.41%
Revenue / Employee (1Y)
‪2.29 M‬ USD
Net income / Employee (1Y)
‪690.35 K‬ USD

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Generic
CEO
Nasrat A. Hakim
Website
elitepharma.com
Headquarters
Northvale
Founded
1997
IPO date
Feb 20, 2014
ISIN
US28659T2006
CUSIP
28659T200
FIGI
BBG000DPZTK5
Identifiers
ISIN US28659T2006
Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the following segments: Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


ELTP stock is 5.96% volatile and has beta coefficient of −0.07.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like ELTP are typically less volatile than smaller companies

Track every detail on Elite Pharmaceuticals, Inc. stock chart and check out the list of the most volatile stocks — is Elite Pharmaceuticals, Inc. there?
To understand the ELTP stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −0.37%
– 1 week — +3.41%
– 1 month — −10.40%

ELTP all-time low was 0.0230 USD (Dec 6, 2021), and its highest price is 24.5000 USD (Mar 7, 2000). Find more dynamics in the Stock Heatmap and on the Elite Pharmaceuticals, Inc. stock chart.
Elite Pharmaceuticals, Inc. market capitalization is ‪256.04 M‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Elite Pharmaceuticals, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Elite Pharmaceuticals, Inc. stacks up against other companies
The safest way to buy Elite Pharmaceuticals, Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade ELTP directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 10, 2026, the company has 65 employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Investing in Elite Pharmaceuticals, Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Elite Pharmaceuticals, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our ELTP technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell

Combine fundamental and technical analysis for better results.
Elite Pharmaceuticals, Inc. stock ticker depends on the exchange where it’s listed. On the OTC, its primary exchange, Elite Pharmaceuticals, Inc. stocks trade under the symbol ELTP.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
Yes, you can track Elite Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
ELTP net income for the last quarter is ‪5.91 M‬ USD, while the quarter before that showed ‪18.46 M‬ USD of net income which accounts for −67.98% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Elite Pharmaceuticals, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Elite Pharmaceuticals, Inc. does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
ELTP reached its all-time high of 24.5000 USD on Mar 7, 2000. Its all-time low was 0.0230 USD and was reached on Dec 6, 2021.

Explore the Elite Pharmaceuticals, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Elite Pharmaceuticals, Inc. EBITDA is ‪37.79 M‬ USD, with an EBITDA margin of 34.92%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in Elite Pharmaceuticals, Inc. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality